Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF MARCH 15, 2009 FBO #2666
SOLICITATION NOTICE

Q -- Advanced Therapeutics for Treating Neutropenia Resulting from Acute Exposure to Ionizing Radiation - Solicitation

Notice Date
3/13/2009
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
541711 — Research and Development in Biotechnology
 
Contracting Office
Department of Health and Human Services, Office of the Secretary, Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, 330 Independence Avenue, SW, Rm G640, Washington, District of Columbia, 20201, United States
 
ZIP Code
20201
 
Solicitation Number
BARDA-09-100-SOL-00005
 
Point of Contact
Anthony Kram,, Phone: 202-205-4709
 
E-Mail Address
anthony.kram@hhs.gov
 
Small Business Set-Aside
N/A
 
Description
Solicitation/RFP for Advanced Therapeutics for Treating Neutropenia The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services (HHS), provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies. BARDA’s mission includes managing the advanced research and development of medical countermeasures (MCM) for chemical, biological, radiological, and nuclear agents (CBRN). As part of its CBRN medical countermeasure development and preparedness mission, BARDA contemplates a five year Cost Reimbursement, multiple award contract for the advanced development and manufacturing of therapeutics on the path to licensure or market approval (i.e., BLA or NDA, respectively) for the indication of treating neutropenia arising from acute exposure to ionizing radiation, (Acute Radiation Syndrome, ARS). This solicitation supports ARS product development activities on the path to obtaining a New Drug Application (NDA) or a Biologic License Application (BLA). NOTE: This solicitation does not acquire product for delivery to the Strategic National Stockpile. This requirement was synopsized under HHS-BARDA-09-33 "Advanced Therapeutics for Treating Neutropenia Resulting from Acute Exposure to Ionizing Radiation" posted on January 16, 2009.
 
Web Link
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=a142ff79a6b37bf97ec2181a87b7b2bb&tab=core&_cview=1)
 
Record
SN01769321-W 20090315/090313220707-a142ff79a6b37bf97ec2181a87b7b2bb (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.